Targeted therapies for epithelial cancers: In vivo efficacy of the BCL-2/BCL-XL inhibitor 2-MeAA

Authors :: David M. Hockenbery
Pamela S. Schwartz
Source :: Cancer Biology & Therapy. 6:465-466
Publication Year :: 2007
Publisher :: Informa UK Limited, 2007.
Abstract: Commentary to:Bcl2/bcl-xl Inhibitor Engenders Apoptosis and Increases Chemo-sensitivity In MesotheliomaXiaobo Cao, Charles Rodarts, Lidong Zhang, Clinton D. Morgan, James Littlejohn and W. Roy SmytheCancer Biology & Therapy Volume: 6 | Issue: 2 | Pages: 246 - 252

Subjects :: Pharmacology
Cancer Research
Chemotherapy
medicine.medical_treatment
Carcinoma
bcl-X Protein
Antimycin A
Biology
Bcl 2 bcl xl
Animal model
Proto-Oncogene Proteins c-bcl-2
Oncology
BH3 peptide
In vivo
Apoptosis
Cell Line, Tumor
medicine
Humans
Molecular Medicine

Full Text Access

Tools